✦ LIBER ✦

Treatment effectiveness and adherence in patients with schizophrenia treated with risperidone long-acting injection

✍ Scribed by Chen-Lin Chang; Dong-Sheng Tzeng; For-Wey Lung

Book ID: 116849985
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 148 KB
Volume: 180
Category: Article
ISSN: 0165-1781
DOI: 10.1016/j.psychres.2009.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

26 – Remission in patients with schizoph

26 – Remission in patients with schizophrenia treated with risperidone long-acting injection (RLAI)

✍ J. Peuskens; M. Povey; J. Van Der Veken; A. Jacobs 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Long-term treatment with long-acting ris

Long-term treatment with long-acting risperidone in Korean patients with schizophrenia

✍ Moon-Soo Lee; Young-Hoon Ko; Sang-Hoon Lee; Yong-Jin Seo; Seung-Hyun Kim; Sook-H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## Objectives We evaluated the efficacy and safety of long‐acting risperidone for 48‐week period in Korean patients. ## Methods This was a non‐randomized, open‐label, single‐centered, 48‐week study. Each of the participants visited the hospital every 2 weeks, and injections were give

Experience with out-patients treated wit

Experience with out-patients treated with long-acting injectable risperidone

✍ P.M. Holgado Madera; J. Diez Martin; E. Bermudez Vazquez; R. Lopez Mateos 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 55 KB

Long-term outcomes in patients with schi

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)

✍ J.M. Olivares; A. Rodriguez-Morales; J. Diels; M. Povey; A. Jacobs; Z. Zhao; A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 326 KB

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

EFFICACY AND TOLERABILITY AMONG PATIENTS

EFFICACY AND TOLERABILITY AMONG PATIENTS WITH RECENT ONSET SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG-ACTING INJECTABLE (RLAI)

✍ Oleksandr Napryeyenko; Benjaminas Burba; Guadalupe Martinez; Nikolay Neznanov; T 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB